Autoantibodies / (Record no. 9278)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 05704pam a2200277 a 4500 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | OSt |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20230925052527.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 960312s1996 ne a b 001 0 eng c |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 0444823832 |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | BUL |
Transcribing agency | BUL |
Modifying agency | BUL |
Language of cataloging | eng |
Description conventions | rda |
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | QW 575.5 A8 A939 1996 |
Item number | A8 A939 1996 |
245 00 - TITLE STATEMENT | |
Title | Autoantibodies / |
Statement of responsibility, etc. | editors, James B. Peter, Yehuda Shoenfeld. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Place of publication, distribution, etc. | Amsterdam ; |
-- | New York : |
Name of publisher, distributor, etc. | Elsevier, |
Date of publication, distribution, etc. | 1996. |
300 ## - PHYSICAL DESCRIPTION | |
Extent | xxix, 880 p. : |
Other physical details | ill. ; |
Dimensions | 27 cm. |
504 ## - BIBLIOGRAPHY, ETC. NOTE | |
Bibliography, etc. note | Includes bibliographical references and index. |
505 ## - FORMATTED CONTENTS NOTE | |
Formatted contents note | Contents<br/><br/>Foreword:The Uses of Autoantibodies. <br/>Acetylcholine Receptor Autoantibodies. <br/>Actin Autoantibodies.<br/>Affinity and Avidity of Autoantibodies. <br/>Alpha-Galactosyl (ANTI-GAL) Autoantibodies. <br/>Aminoacyl-tRNAHistidyl (Jo-1) Synthetase Autoantibodies. <br/>Aminoacyl-tRNA (other than Histidyl) Synthetase Autoantibodies. <br/>Antineutrophil Cytoplasmic Antibodies in Inflammatory Bowel Diseases. <br/>Antineutrophil Cytoplasmic Autoantibodies with Specificity for Myeloperoxidase. <br/>Antineutrophil Cytoplasmic Autoantibodies withSpecificity for Proteinase 3. <br/>Antineutrophil Cytoplasmic Autoantibodies with Specificity other than PR3 and MPO (X-ANCA). <br/>Antinuclear Antibodies.<br/> Autoantibodies in Therapeutic Preparations of Human IgG (IVIg). <br/>Autoantibodies that Penetrate into Living Cells. <br/>Autoantibody Subclasses. <br/>B2-Glycoprotein I Autoantibodies. <br/>Beta-Adrenergic Receptor (and other hormone receptor) Autoantibodies. <br/>Bromelain-treated ErythrocyteAutoantibodies. <br/>C1 Inhibitor Autoantibodies. <br/>C1q Autoantibodies. <br/>Calcium Channel and Related Paraneoplastic Disease Autoantibodies. <br/>Calcium Channel Autoantibodies and Amyotrophic Lateral Sclerosis. <br/>Centriole and Centrosome Autoantibodies. <br/>Centromere Autoantibodies. <br/>Chromo Autoantibodies. <br/>CoagulationFactor VIII Autoantibodies. <br/>Coagulation Factor (excluding Factor VIII) Autoantibodies. <br/>Collagen Autoantibodies. <br/>Cryoglobulins. <br/>Cryoglobulins Secondary to Hepatitis C Virus Infection. <br/>Cytokine Autoantibodies. Cytoskeletal Autoantibodies. <br/>dsDNA Autoantibodies. <br/>Endomysial Autoantibodies. <br/>Endothelial Cell Autoantibodies. <br/>Fibrillarin Autoantibodies. <br/>Fibronectin Autoantibodies. <br/>56-kd Nuclear Protein Autoantibodies. <br/>Filaggrin (Keratin) Autoantibodies. <br/>Ganglioside Autoantibodies. <br/>Gliadin Antibodies. <br/>Glomerular Basement Membrane Autoantibodies. <br/>Glutamic Acid Decarboxylase Autoantibodies in DiabetesMellitus. <br/>Glutamic Acid Decarboxylase Autoantibodies in Stiff-Man Syndrome. <br/>Glycolipid (excluding Ganglioside) Autoantibodies. <br/>Golgi Apparatus Autoantibodies. <br/>Granulocyte-Specific Antinuclear Antibodies. <br/>Heat Shock Protein Autoantibodies. <br/>Heparin-Associated Autoantibodies. <br/>Heterophile Antibodies. <br/>Hidden Autoantibodies. <br/>Histone (H2A-H2B)-DNA Autoantibodies. <br/>Histone Autoantibodies other than (H2A-H2B)- DNA Autoantibodies. <br/>Hormone Nonpeptide Autoantibodies: THYROID. <br/>Hormone Peptide Autoantibodies. <br/>Human Antimouse Antibodies. <br/>Idiotypes and Anti-Idiotypic Antibodies. <br/>IgA Autoantibodies. <br/>IgE Receptor Autoantibodies. <br/>Insulin Autoantibodies. <br/>Interferon-Inducible Protein IFI 16 Autoantibodies. <br/>Islet Cell Autoantibodies. <br/>Ku and Ki Autoantibodies. <br/>Liver Cytosol Antigen Type 1 Autoantibodies. <br/>Liver/Kidney Microsomal Autoantibodies. <br/>Liver Membrane Autoantibodies. <br/>Lupus Anticoagulant. <br/>Lymphocytotoxic Autoantibodies. <br/>Mi-2 Autoantibodies. <br/>Mitochondrial Autoantibodies. <br/>Mitotic Spindle Apparatus Autoantibodies. <br/>Molecular Mimicry. <br/>Myelin-Associated Glycoprotein Autoantibodies. <br/>Myelin Basic ProteinAutoantibodies. <br/>Myocardial Autoantibodies. <br/>Natural Autoantibodies. <br/>Nephritic Factor Autoantibodies. <br/>Neuronal Autoantibodies. <br/>Neuronal Nuclear Autoantibodies, Type 1 (Hu). <br/>Neutrophil Autoantibodies. <br/>Nuclear Envelope Protein Autoantibodies. <br/>Nucleolar Autoantibodies. <br/>Nucleosome-Specific Autoantibodies. <br/>Other Autoantibodies to Nuclear Antigens. <br/>p53 Autoantibodies. <br/>Parietal Cell Autoantibodies. <br/>Pathogenic Mechanisms. <br/>Perinuclear Factor (Profilaggrin) Autoantibodies. <br/>Phospholipid Autoantibodies - Cardiolipin.Phospholipid Autoantibodies - Phosphatidylserine. <br/>Platelet Autoantibodies. <br/>PM-SCL Autoantibodies. <br/>Proliferating Cell Nuclear Antigen Autoantibodies. <br/>Purkinje Cell Autoantibodies, TYPE 1 (Yo). RA-33 (Heterogeneous Nuclear Ribonucleoprotein Complex) Autoantibodies. <br/>Recombinant Autoantigens. <br/>Red CellAutoantibodies. <br/>Reticulin Autoantibodies. <br/>Retinal Autoantibodies. <br/>Retroviral Antibodies. <br/>Rheumatoid Factors. <br/>Ribosomal Autoantibodies. <br/>Ribosomal P Protein Autoantibodies. <br/>RNA Polymerase I-III Autoantibodies. <br/>Signal Recognition Particle Autoantibodies. <br/>Silicate and Silicone Antibodies. <br/>Skin Diseases Autoantibodies. <br/>Smooth Muscle Autoantibodies. <br/>Spliceosomal snRNPS Autoantibodies. <br/>SS-A (Ro) Autoantibodies. <br/>SS-B (La) Autoantibodies. <br/>Steroid Cell Autoantibodies. <br/>Striational Autoantibodies. <br/>Thyroglobulin Autoantibodies.<br/>Thyroid Peroxidase Autoantibodies. <br/>Thyrotropin Receptor Autoantibodies. <br/>Topoisomerase-I (Scl-70) Autoantibodies. <br/>Tubular Basement Membrane Autoantibodies. <br/>Tyrosinase Autoantibodies. <br/>Xenoreactive Human Natural Antibodies. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Autoantibodies. |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Autoantibodies. |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Autoimmune Diseases |
General subdivision | etiology. |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Peter, James B. |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Shoenfeld, Yehuda. |
856 42 - ELECTRONIC LOCATION AND ACCESS | |
Materials specified | Publisher description |
Uniform Resource Identifier | <a href="http://www.loc.gov/catdir/enhancements/fy0601/96013604-d.html">http://www.loc.gov/catdir/enhancements/fy0601/96013604-d.html</a> |
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) | |
a | 7 |
b | cbc |
c | orignew |
d | 1 |
e | ocip |
f | 19 |
g | y-gencatlg |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Source of classification or shelving scheme | Dewey Decimal Classification |
Koha item type | Book Open Access |
Classification part | QW 575.5 A8 A939 1996 |
Item part | 1 |
Call number prefix | QW 575.5 |
Call number suffix | A8 A939 1996 |
Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Source of acquisition | Inventory number | Total Checkouts | Full call number | Barcode | Date last seen | Copy number | Price effective from | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dewey Decimal Classification | Health Sciences Library | Health Sciences Library | 01/20/2022 | Donation | 00583 | QW 575.5 A8 A939 1996 | MBAL22010840 | 01/20/2022 | 1 | 01/20/2022 | Book Open Access |